Terra Health Review
Black and Latino-founded GLP-1 telehealth clinic offering affordable compounded semaglutide and tirzepatide with a focus on equitable access and culturally responsive care.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Quick Verdict
A mission-driven GLP-1 clinic with a genuine focus on health equity. The $249/mo all-inclusive pricing is competitive, and the culturally responsive care model fills a real gap in the telehealth market.
- Black and Latino-founded with health equity mission
- Bilingual (Spanish/English) care available
- All-inclusive pricing from $249/mo
- Injectable and oral semaglutide options
- Monthly provider check-ins included
- All 50 states
- GLP-1 only — no hormone or longevity protocols
- Compounded medications are not FDA-approved drugs
- Newer brand with limited independent review history
Terra Health Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Terra Health.
| Program / Membership Fee | Included in monthly plan |
| Medication Cost (From) | From $249 – $349/mo |
Terra Health plans start at $249/mo with medication included. Injectable semaglutide, injectable tirzepatide, and oral semaglutide are all available. No insurance required. Monthly check-ins with licensed providers are included.
Who Terra Health Is For
Terra Health is particularly well-suited for Black and Latino patients who have felt underserved or unheard in traditional healthcare settings. The bilingual care option and the founder mission around health equity make it a distinctive choice in the GLP-1 market.
Adults — particularly from Black and Latino communities — who want affordable, judgment-free GLP-1 care from licensed providers who understand the unique health challenges of underserved populations.
Signature Programs
- ›Compounded semaglutide (injectable and oral)
- ›Compounded tirzepatide
- ›Monthly provider check-ins
- ›Bilingual (Spanish/English) care available
Medication Formulary
How Terra Health Scores
Terra Health scores 4.4 / 5 overall (cost 4.5, experience 4.4, trust 4.3), which makes it one of the strong mid-tier options in the GLP-1 weight loss category we cover.
See how Terra Health compares in our full GLP-1 weight loss rankings, or read the Best Compounded GLP-1 Telehealth Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
How much does Terra Health cost per month?
Terra Health's published pricing runs $249 to $349 per month. Terra Health plans start at $249/mo with medication included. Injectable semaglutide, injectable tirzepatide, and oral semaglutide are all available. No insurance required. Monthly check-ins with licensed providers are included. Confirm the all-in monthly total at checkout, because telehealth pricing changes without notice.
What medications does Terra Health prescribe?
Terra Health lists compounded semaglutide, compounded tirzepatide, oral semaglutide. It focuses on compounded medications rather than FDA-approved brand-name drugs. What you are prescribed depends on the clinician's assessment and your state.
Is Terra Health legit?
Terra Health connects patients with licensed clinicians for GLP-1 weight loss care. We score its trust and transparency at 4.3/5. Before ordering, check that the clinician is licensed in your state and, for compounded drugs, which pharmacy fills the prescription.
Can I cancel Terra Health anytime?
Most telehealth plans, Terra Health's included, are cancelled through the patient portal or support team, but refund terms vary. Compounded medication is made to order, so shipments are usually non-refundable once dispensed. Read the current terms before your first refill date to avoid an unwanted renewal.
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
- Lincoff et al., NEJM 2023 (SELECT trial) · Semaglutide 2.4 mg reduced major cardiovascular events by 20% in adults with overweight/obesity and established cardiovascular disease.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
